l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with lafutidine in 1 studies
| Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (lafutidine) | Trials (lafutidine) | Recent Studies (post-2010) (lafutidine) |
|---|---|---|---|---|---|
| 138 | 7 | 2 | 112 | 29 | 31 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurosawa, M; Terano, A; Watanobe, H; Yoneda, M | 1 |
1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and lafutidine
| Article | Year |
|---|---|
Lafutidine increases hepatic blood flow via potentiating the action of central thyrotropin-releasing hormone in rats.
Topics: Acetamides; Analysis of Variance; Animals; Capsaicin; Drug Combinations; Drug Synergism; Gastric Mucosa; Histamine H2 Antagonists; Laser-Doppler Flowmetry; Liver; Liver Circulation; Male; Neurons, Afferent; Piperidines; Pyridines; Pyrrolidonecarboxylic Acid; Rats; Rats, Wistar; Receptors, Calcitonin Gene-Related Peptide; Thyrotropin-Releasing Hormone | 2003 |